Some studies suggest increased myostatin levels with age (Wilhelmsen et al., 2024) and indeed myostatin/activin pathway dysregulation is strongly implicated in the development of sarcopenia (Amthor and Hoogaars, 2012). The gene discussed is MSTN; the disease is sarcopenia.